chr1:246589156-246609712 |
chr1:246602240 |
rs10924730 |
SMYD3 |
Multiple complex diseases |
intron |
2.28e-05 |
GWASdb |
| chr1:246019161-246045293 |
chr1:246027410 |
rs10924366 |
SMYD3 |
Multiple complex diseases |
intron |
0.000935 |
GWASdb |
| chr1:246303369-246357366 |
chr1:246310748 |
rs6692380 |
SMYD3 |
Type 2 diabetes |
intron |
0.000611 |
GWASdb |
| chr1:246303369-246357366 |
chr1:246319482 |
rs4654092 |
SMYD3 |
Prostate cancer |
intron |
1.74e-05 |
GWASdb |
| chr1:246303369-246357366 |
chr1:246330176 |
rs4654216 |
SMYD3 |
Multiple complex diseases |
intron |
0.00077 |
GWASdb |
| chr1:246019111-246045592 |
chr1:246027410 |
rs10924366 |
SMYD3 |
Multiple complex diseases |
intron |
0.000935 |
GWASdb |
| chr1:246106312-246169625 |
chr1:246125283 |
rs1544149 |
SMYD3 |
HIV-1 viral setpoint |
intron |
0.000182 |
GWASdb |
| chr1:246106312-246169625 |
chr1:246144436 |
rs4654179 |
SMYD3 |
Diabetic nephropathy |
intron |
6.53e-05 |
GWASdb |
| chr1:246106312-246169625 |
chr1:246146328 |
rs1538294 |
SMYD3 |
HIV-1 viral setpoint |
intron |
0.000753 |
GWASdb |
| chr1:246106312-246169625 |
chr1:246148791 |
rs4654180 |
SMYD3 |
Diabetic nephropathy |
intron |
3.68e-05 |
GWASdb |
| chr1:246106312-246169625 |
chr1:246152478 |
rs10802308 |
SMYD3 |
Multiple complex diseases |
intron |
0.000129 |
GWASdb |
| chr1:246106312-246169625 |
chr1:246162256 |
rs2105158 |
SMYD3 |
Diabetic nephropathy |
intron |
2.06e-05 |
GWASdb |
| chr1:246018925-246045662 |
chr1:246027410 |
rs10924366 |
SMYD3 |
Multiple complex diseases |
intron |
0.000935 |
GWASdb |
| chr1:246019001-246045931 |
chr1:246027410 |
rs10924366 |
SMYD3 |
Multiple complex diseases |
intron |
0.000935 |
GWASdb |
| chr1:246022411-246040682 |
chr1:246027410 |
rs10924366 |
SMYD3 |
Multiple complex diseases |
intron |
0.000935 |
GWASdb |
| chr1:246019303-246045614 |
chr1:246027410 |
rs10924366 |
SMYD3 |
Multiple complex diseases |
intron |
0.000935 |
GWASdb |
| chr1:246109784-246169549 |
chr1:246125283 |
rs1544149 |
SMYD3 |
HIV-1 viral setpoint |
intron |
0.000182 |
GWASdb |
| chr1:246109784-246169549 |
chr1:246144436 |
rs4654179 |
SMYD3 |
Diabetic nephropathy |
intron |
6.53e-05 |
GWASdb |
| chr1:246109784-246169549 |
chr1:246146328 |
rs1538294 |
SMYD3 |
HIV-1 viral setpoint |
intron |
0.000753 |
GWASdb |
| chr1:246109784-246169549 |
chr1:246148791 |
rs4654180 |
SMYD3 |
Diabetic nephropathy |
intron |
3.68e-05 |
GWASdb |
| chr1:246109784-246169549 |
chr1:246152478 |
rs10802308 |
SMYD3 |
Multiple complex diseases |
intron |
0.000129 |
GWASdb |
| chr1:246109784-246169549 |
chr1:246162256 |
rs2105158 |
SMYD3 |
Diabetic nephropathy |
intron |
2.06e-05 |
GWASdb |
| chr1:245950297-245965298 |
chr1:245960086 |
rs2817478 |
SMYD3 |
Insulin resistance |
intron |
8.82e-05 |
GWASdb |
| chr1:245950297-245965298 |
chr1:245960306 |
rs2791393 |
SMYD3 |
Urinary metabolites |
intron |
7.2e-06 |
GWASdb |
| chr1:245950297-245965298 |
chr1:245960306 |
rs2791393 |
SMYD3 |
Insulin resistance |
intron |
4.53e-05 |
GWASdb |
| chr1:245950297-245965298 |
chr1:245962202 |
rs2817475 |
SMYD3 |
Nicotine smoking |
intron |
0.000467 |
GWASdb |
| chr1:245928784-245936866 |
chr1:245932792 |
rs2247524 |
SMYD3 |
Response to taxane treatment (placlitaxel) |
intron |
0.000301 |
GWASdb |
| chr1:246114832-246169462 |
chr1:246125283 |
rs1544149 |
SMYD3 |
HIV-1 viral setpoint |
intron |
0.000182 |
GWASdb |
| chr1:246114832-246169462 |
chr1:246144436 |
rs4654179 |
SMYD3 |
Diabetic nephropathy |
intron |
6.53e-05 |
GWASdb |
| chr1:246114832-246169462 |
chr1:246146328 |
rs1538294 |
SMYD3 |
HIV-1 viral setpoint |
intron |
0.000753 |
GWASdb |
| chr1:246114832-246169462 |
chr1:246148791 |
rs4654180 |
SMYD3 |
Diabetic nephropathy |
intron |
3.68e-05 |
GWASdb |
| chr1:246114832-246169462 |
chr1:246152478 |
rs10802308 |
SMYD3 |
Multiple complex diseases |
intron |
0.000129 |
GWASdb |
| chr1:246114832-246169462 |
chr1:246162256 |
rs2105158 |
SMYD3 |
Diabetic nephropathy |
intron |
2.06e-05 |
GWASdb |
| chr1:246019408-246045837 |
chr1:246027410 |
rs10924366 |
SMYD3 |
Multiple complex diseases |
intron |
0.000935 |
GWASdb |
| chr1:245950375-245966178 |
chr1:245960086 |
rs2817478 |
SMYD3 |
Insulin resistance |
intron |
8.82e-05 |
GWASdb |
| chr1:245950375-245966178 |
chr1:245960306 |
rs2791393 |
SMYD3 |
Urinary metabolites |
intron |
7.2e-06 |
GWASdb |
| chr1:245950375-245966178 |
chr1:245960306 |
rs2791393 |
SMYD3 |
Insulin resistance |
intron |
4.53e-05 |
GWASdb |
| chr1:245950375-245966178 |
chr1:245962202 |
rs2817475 |
SMYD3 |
Nicotine smoking |
intron |
0.000467 |
GWASdb |
| chr1:245928783-245937005 |
chr1:245932792 |
rs2247524 |
SMYD3 |
Response to taxane treatment (placlitaxel) |
intron |
0.000301 |
GWASdb |
| chr1:246022292-246044464 |
chr1:246027410 |
rs10924366 |
SMYD3 |
Multiple complex diseases |
intron |
0.000935 |
GWASdb |
| chr1:246131748-246151038 |
chr1:246144436 |
rs4654179 |
SMYD3 |
Diabetic nephropathy |
intron |
6.53e-05 |
GWASdb |
| chr1:246131748-246151038 |
chr1:246146328 |
rs1538294 |
SMYD3 |
HIV-1 viral setpoint |
intron |
0.000753 |
GWASdb |
| chr1:246131748-246151038 |
chr1:246148791 |
rs4654180 |
SMYD3 |
Diabetic nephropathy |
intron |
3.68e-05 |
GWASdb |
| chr1:246019255-246045469 |
chr1:246027410 |
rs10924366 |
SMYD3 |
Multiple complex diseases |
intron |
0.000935 |
GWASdb |
| chr1:246148674-246169460 |
chr1:246148791 |
rs4654180 |
SMYD3 |
Diabetic nephropathy |
intron |
3.68e-05 |
GWASdb |
| chr1:246148674-246169460 |
chr1:246152478 |
rs10802308 |
SMYD3 |
Multiple complex diseases |
intron |
0.000129 |
GWASdb |
| chr1:246148674-246169460 |
chr1:246162256 |
rs2105158 |
SMYD3 |
Diabetic nephropathy |
intron |
2.06e-05 |
GWASdb |
| chr1:245950544-245965443 |
chr1:245960086 |
rs2817478 |
SMYD3 |
Insulin resistance |
intron |
8.82e-05 |
GWASdb |
| chr1:245950544-245965443 |
chr1:245960306 |
rs2791393 |
SMYD3 |
Urinary metabolites |
intron |
7.2e-06 |
GWASdb |
| chr1:245950544-245965443 |
chr1:245960306 |
rs2791393 |
SMYD3 |
Insulin resistance |
intron |
4.53e-05 |
GWASdb |
| chr1:245950544-245965443 |
chr1:245962202 |
rs2817475 |
SMYD3 |
Nicotine smoking |
intron |
0.000467 |
GWASdb |
| chr1:246115820-246169429 |
chr1:246125283 |
rs1544149 |
SMYD3 |
HIV-1 viral setpoint |
intron |
0.000182 |
GWASdb |
| chr1:246115820-246169429 |
chr1:246144436 |
rs4654179 |
SMYD3 |
Diabetic nephropathy |
intron |
6.53e-05 |
GWASdb |
| chr1:246115820-246169429 |
chr1:246146328 |
rs1538294 |
SMYD3 |
HIV-1 viral setpoint |
intron |
0.000753 |
GWASdb |
| chr1:246115820-246169429 |
chr1:246148791 |
rs4654180 |
SMYD3 |
Diabetic nephropathy |
intron |
3.68e-05 |
GWASdb |
| chr1:246115820-246169429 |
chr1:246152478 |
rs10802308 |
SMYD3 |
Multiple complex diseases |
intron |
0.000129 |
GWASdb |
| chr1:246115820-246169429 |
chr1:246162256 |
rs2105158 |
SMYD3 |
Diabetic nephropathy |
intron |
2.06e-05 |
GWASdb |
| chr1:246019254-246045616 |
chr1:246027410 |
rs10924366 |
SMYD3 |
Multiple complex diseases |
intron |
0.000935 |
GWASdb |
| chr1:245950398-245964591 |
chr1:245960086 |
rs2817478 |
SMYD3 |
Insulin resistance |
intron |
8.82e-05 |
GWASdb |
| chr1:245950398-245964591 |
chr1:245960306 |
rs2791393 |
SMYD3 |
Urinary metabolites |
intron |
7.2e-06 |
GWASdb |
| chr1:245950398-245964591 |
chr1:245960306 |
rs2791393 |
SMYD3 |
Insulin resistance |
intron |
4.53e-05 |
GWASdb |
| chr1:245950398-245964591 |
chr1:245962202 |
rs2817475 |
SMYD3 |
Nicotine smoking |
intron |
0.000467 |
GWASdb |
| chr1:245928711-245936730 |
chr1:245928778 |
rs2791380 |
SMYD3 |
Multiple complex diseases |
intron |
3e-04 |
GWASdb |
| chr1:245928711-245936730 |
chr1:245932792 |
rs2247524 |
SMYD3 |
Response to taxane treatment (placlitaxel) |
intron |
0.000301 |
GWASdb |
| chr1:246226236-246250247 |
chr1:246241574 |
rs61839075 |
SMYD3 |
Sarcoidosis |
intron |
3.939e-05 |
GWASdb |
| chr1:246228288-246281142 |
chr1:246241574 |
rs61839075 |
SMYD3 |
Sarcoidosis |
intron |
3.939e-05 |
GWASdb |
| chr1:246372569-246384743 |
chr1:246372880 |
rs10802346 |
SMYD3 |
Fractional exhaled nitric oxide (childhood) |
intron |
7.17e-05 |
GWASdb |
| chr1:246372569-246384743 |
chr1:246372880 |
rs10802346 |
SMYD3 |
Fractional exhaled nitric oxide (childhood) |
intron |
8e-06 |
GWASdb |
| chr1:246372569-246384743 |
chr1:246378041 |
rs10924556 |
SMYD3 |
Multiple complex diseases |
intron |
0.000488 |
GWASdb |
| chr1:246302029-246324862 |
chr1:246310748 |
rs6692380 |
SMYD3 |
Type 2 diabetes |
intron |
0.000611 |
GWASdb |
| chr1:246302029-246324862 |
chr1:246319482 |
rs4654092 |
SMYD3 |
Prostate cancer |
intron |
1.74e-05 |
GWASdb |
| chr1:246022642-246044268 |
chr1:246027410 |
rs10924366 |
SMYD3 |
Multiple complex diseases |
intron |
0.000935 |
GWASdb |
| chr1:246022714-246045370 |
chr1:246027410 |
rs10924366 |
SMYD3 |
Multiple complex diseases |
intron |
0.000935 |
GWASdb |
| chr1:246018992-246060750 |
chr1:246027410 |
rs10924366 |
SMYD3 |
Multiple complex diseases |
intron |
0.000935 |
GWASdb |
| chr1:246018992-246060750 |
chr1:246054787 |
rs4654164 |
SMYD3 |
Lung function (forced vital capacity) |
intron |
0.000352 |
GWASdb |
| chr1:246018992-246060750 |
chr1:246057046 |
rs9728343 |
SMYD3 |
Lung function (forced vital capacity) |
intron |
0.000287 |
GWASdb |
| chr1:246018992-246060750 |
chr1:246058909 |
rs4654068 |
SMYD3 |
Height |
intron |
1.79e-05 |
GWASdb |
| chr1:246018992-246060750 |
chr1:246058909 |
rs4654068 |
SMYD3 |
Height |
intron |
7.99e-07 |
GWASdb |
| chr1:246018992-246060750 |
chr1:246058909 |
rs4654068 |
SMYD3 |
Waist Circumference |
intron |
3.34e-05 |
GWASdb |
| chr1:246018992-246060750 |
chr1:246059818 |
rs6693295 |
SMYD3 |
Migraine with aura |
intron_variant |
6e-06 |
GWAS_Catalog |
| chr1:246018992-246060750 |
chr1:246059818 |
rs6693295 |
SMYD3 |
Migraine - clinic-based |
intron_variant |
9e-06 |
GWAS_Catalog |
| chr1:245911117-245971991 |
chr1:245915582 |
rs2185368 |
SMYD3 |
Response to taxane treatment (placlitaxel) |
intron |
0.000271 |
GWASdb |
| chr1:245911117-245971991 |
chr1:245926038 |
rs12088988 |
SMYD3 |
Multiple complex diseases |
intron |
0.00065 |
GWASdb |
| chr1:245911117-245971991 |
chr1:245926485 |
rs2817506 |
SMYD3 |
Multiple complex diseases |
intron |
0.000447 |
GWASdb |
| chr1:245911117-245971991 |
chr1:245928778 |
rs2791380 |
SMYD3 |
Multiple complex diseases |
intron |
3e-04 |
GWASdb |
| chr1:245911117-245971991 |
chr1:245932792 |
rs2247524 |
SMYD3 |
Response to taxane treatment (placlitaxel) |
intron |
0.000301 |
GWASdb |
| chr1:245911117-245971991 |
chr1:245960086 |
rs2817478 |
SMYD3 |
Insulin resistance |
intron |
8.82e-05 |
GWASdb |
| chr1:245911117-245971991 |
chr1:245960306 |
rs2791393 |
SMYD3 |
Urinary metabolites |
intron |
7.2e-06 |
GWASdb |
| chr1:245911117-245971991 |
chr1:245960306 |
rs2791393 |
SMYD3 |
Insulin resistance |
intron |
4.53e-05 |
GWASdb |
| chr1:245911117-245971991 |
chr1:245962202 |
rs2817475 |
SMYD3 |
Nicotine smoking |
intron |
0.000467 |
GWASdb |
| chr1:245911117-245971991 |
chr1:245917498 |
rs116335148 |
SMYD3, LOC105373269 |
Post bronchodilator FEV1 |
intron_variant |
4e-06 |
GWAS_Catalog |
| chr1:245911117-245971991 |
chr1:245919582 |
rs116647499 |
LOC105373269, SMYD3 |
Post bronchodilator FEV1 |
intron_variant |
4e-06 |
GWAS_Catalog |
| chr1:245911117-245971991 |
chr1:245913962 |
rs115107872 |
SMYD3, LOC105373269 |
Post bronchodilator FEV1 |
intron_variant |
4e-06 |
GWAS_Catalog |
| chr1:246115804-246169665 |
chr1:246125283 |
rs1544149 |
SMYD3 |
HIV-1 viral setpoint |
intron |
0.000182 |
GWASdb |
| chr1:246115804-246169665 |
chr1:246144436 |
rs4654179 |
SMYD3 |
Diabetic nephropathy |
intron |
6.53e-05 |
GWASdb |
| chr1:246115804-246169665 |
chr1:246146328 |
rs1538294 |
SMYD3 |
HIV-1 viral setpoint |
intron |
0.000753 |
GWASdb |
| chr1:246115804-246169665 |
chr1:246148791 |
rs4654180 |
SMYD3 |
Diabetic nephropathy |
intron |
3.68e-05 |
GWASdb |
| chr1:246115804-246169665 |
chr1:246152478 |
rs10802308 |
SMYD3 |
Multiple complex diseases |
intron |
0.000129 |
GWASdb |
| chr1:246115804-246169665 |
chr1:246162256 |
rs2105158 |
SMYD3 |
Diabetic nephropathy |
intron |
2.06e-05 |
GWASdb |
| chr1:246227102-246281269 |
chr1:246241574 |
rs61839075 |
SMYD3 |
Sarcoidosis |
intron |
3.939e-05 |
GWASdb |
| chr1:246019202-246045898 |
chr1:246027410 |
rs10924366 |
SMYD3 |
Multiple complex diseases |
intron |
0.000935 |
GWASdb |
| chr1:245934531-245979384 |
chr1:245960086 |
rs2817478 |
SMYD3 |
Insulin resistance |
intron |
8.82e-05 |
GWASdb |
| chr1:245934531-245979384 |
chr1:245960306 |
rs2791393 |
SMYD3 |
Urinary metabolites |
intron |
7.2e-06 |
GWASdb |
| chr1:245934531-245979384 |
chr1:245960306 |
rs2791393 |
SMYD3 |
Insulin resistance |
intron |
4.53e-05 |
GWASdb |
| chr1:245934531-245979384 |
chr1:245962202 |
rs2817475 |
SMYD3 |
Nicotine smoking |
intron |
0.000467 |
GWASdb |
| chr1:245936591-245978828 |
chr1:245960086 |
rs2817478 |
SMYD3 |
Insulin resistance |
intron |
8.82e-05 |
GWASdb |
| chr1:245936591-245978828 |
chr1:245960306 |
rs2791393 |
SMYD3 |
Urinary metabolites |
intron |
7.2e-06 |
GWASdb |
| chr1:245936591-245978828 |
chr1:245960306 |
rs2791393 |
SMYD3 |
Insulin resistance |
intron |
4.53e-05 |
GWASdb |
| chr1:245936591-245978828 |
chr1:245962202 |
rs2817475 |
SMYD3 |
Nicotine smoking |
intron |
0.000467 |
GWASdb |
| chr1:246229539-246311271 |
chr1:246241574 |
rs61839075 |
SMYD3 |
Sarcoidosis |
intron |
3.939e-05 |
GWASdb |
| chr1:246229539-246311271 |
chr1:246310748 |
rs6692380 |
SMYD3 |
Type 2 diabetes |
intron |
0.000611 |
GWASdb |
| chr1:245950028-245978061 |
chr1:245960086 |
rs2817478 |
SMYD3 |
Insulin resistance |
intron |
8.82e-05 |
GWASdb |
| chr1:245950028-245978061 |
chr1:245960306 |
rs2791393 |
SMYD3 |
Urinary metabolites |
intron |
7.2e-06 |
GWASdb |
| chr1:245950028-245978061 |
chr1:245960306 |
rs2791393 |
SMYD3 |
Insulin resistance |
intron |
4.53e-05 |
GWASdb |
| chr1:245950028-245978061 |
chr1:245962202 |
rs2817475 |
SMYD3 |
Nicotine smoking |
intron |
0.000467 |
GWASdb |
| chr1:246115967-246169587 |
chr1:246125283 |
rs1544149 |
SMYD3 |
HIV-1 viral setpoint |
intron |
0.000182 |
GWASdb |
| chr1:246115967-246169587 |
chr1:246144436 |
rs4654179 |
SMYD3 |
Diabetic nephropathy |
intron |
6.53e-05 |
GWASdb |
| chr1:246115967-246169587 |
chr1:246146328 |
rs1538294 |
SMYD3 |
HIV-1 viral setpoint |
intron |
0.000753 |
GWASdb |
| chr1:246115967-246169587 |
chr1:246148791 |
rs4654180 |
SMYD3 |
Diabetic nephropathy |
intron |
3.68e-05 |
GWASdb |
| chr1:246115967-246169587 |
chr1:246152478 |
rs10802308 |
SMYD3 |
Multiple complex diseases |
intron |
0.000129 |
GWASdb |
| chr1:246115967-246169587 |
chr1:246162256 |
rs2105158 |
SMYD3 |
Diabetic nephropathy |
intron |
2.06e-05 |
GWASdb |
| chr1:246000453-246053155 |
chr1:246005798 |
rs9728248 |
SMYD3 |
Substance dependence |
intron |
0.000184 |
GWASdb |
| chr1:246000453-246053155 |
chr1:246027410 |
rs10924366 |
SMYD3 |
Multiple complex diseases |
intron |
0.000935 |
GWASdb |
| chr1:245937876-245978412 |
chr1:245960086 |
rs2817478 |
SMYD3 |
Insulin resistance |
intron |
8.82e-05 |
GWASdb |
| chr1:245937876-245978412 |
chr1:245960306 |
rs2791393 |
SMYD3 |
Urinary metabolites |
intron |
7.2e-06 |
GWASdb |
| chr1:245937876-245978412 |
chr1:245960306 |
rs2791393 |
SMYD3 |
Insulin resistance |
intron |
4.53e-05 |
GWASdb |
| chr1:245937876-245978412 |
chr1:245962202 |
rs2817475 |
SMYD3 |
Nicotine smoking |
intron |
0.000467 |
GWASdb |
| chr1:246147517-246170328 |
chr1:246148791 |
rs4654180 |
SMYD3 |
Diabetic nephropathy |
intron |
3.68e-05 |
GWASdb |
| chr1:246147517-246170328 |
chr1:246152478 |
rs10802308 |
SMYD3 |
Multiple complex diseases |
intron |
0.000129 |
GWASdb |
| chr1:246147517-246170328 |
chr1:246162256 |
rs2105158 |
SMYD3 |
Diabetic nephropathy |
intron |
2.06e-05 |
GWASdb |
| chr1:246018802-246053212 |
chr1:246027410 |
rs10924366 |
SMYD3 |
Multiple complex diseases |
intron |
0.000935 |
GWASdb |
| chr1:245950117-245977604 |
chr1:245960086 |
rs2817478 |
SMYD3 |
Insulin resistance |
intron |
8.82e-05 |
GWASdb |
| chr1:245950117-245977604 |
chr1:245960306 |
rs2791393 |
SMYD3 |
Urinary metabolites |
intron |
7.2e-06 |
GWASdb |
| chr1:245950117-245977604 |
chr1:245960306 |
rs2791393 |
SMYD3 |
Insulin resistance |
intron |
4.53e-05 |
GWASdb |
| chr1:245950117-245977604 |
chr1:245962202 |
rs2817475 |
SMYD3 |
Nicotine smoking |
intron |
0.000467 |
GWASdb |
| chr1:245904244-245968676 |
chr1:245915582 |
rs2185368 |
SMYD3 |
Response to taxane treatment (placlitaxel) |
intron |
0.000271 |
GWASdb |
| chr1:245904244-245968676 |
chr1:245926038 |
rs12088988 |
SMYD3 |
Multiple complex diseases |
intron |
0.00065 |
GWASdb |
| chr1:245904244-245968676 |
chr1:245926485 |
rs2817506 |
SMYD3 |
Multiple complex diseases |
intron |
0.000447 |
GWASdb |
| chr1:245904244-245968676 |
chr1:245928778 |
rs2791380 |
SMYD3 |
Multiple complex diseases |
intron |
3e-04 |
GWASdb |
| chr1:245904244-245968676 |
chr1:245932792 |
rs2247524 |
SMYD3 |
Response to taxane treatment (placlitaxel) |
intron |
0.000301 |
GWASdb |
| chr1:245904244-245968676 |
chr1:245960086 |
rs2817478 |
SMYD3 |
Insulin resistance |
intron |
8.82e-05 |
GWASdb |
| chr1:245904244-245968676 |
chr1:245960306 |
rs2791393 |
SMYD3 |
Urinary metabolites |
intron |
7.2e-06 |
GWASdb |
| chr1:245904244-245968676 |
chr1:245960306 |
rs2791393 |
SMYD3 |
Insulin resistance |
intron |
4.53e-05 |
GWASdb |
| chr1:245904244-245968676 |
chr1:245962202 |
rs2817475 |
SMYD3 |
Nicotine smoking |
intron |
0.000467 |
GWASdb |
| chr1:245904244-245968676 |
chr1:245917498 |
rs116335148 |
SMYD3, LOC105373269 |
Post bronchodilator FEV1 |
intron_variant |
4e-06 |
GWAS_Catalog |
| chr1:245904244-245968676 |
chr1:245919582 |
rs116647499 |
LOC105373269, SMYD3 |
Post bronchodilator FEV1 |
intron_variant |
4e-06 |
GWAS_Catalog |
| chr1:245904244-245968676 |
chr1:245913962 |
rs115107872 |
SMYD3, LOC105373269 |
Post bronchodilator FEV1 |
intron_variant |
4e-06 |
GWAS_Catalog |
| chr1:246146647-246165633 |
chr1:246148791 |
rs4654180 |
SMYD3 |
Diabetic nephropathy |
intron |
3.68e-05 |
GWASdb |
| chr1:246146647-246165633 |
chr1:246152478 |
rs10802308 |
SMYD3 |
Multiple complex diseases |
intron |
0.000129 |
GWASdb |
| chr1:246146647-246165633 |
chr1:246162256 |
rs2105158 |
SMYD3 |
Diabetic nephropathy |
intron |
2.06e-05 |
GWASdb |
| chr1:246566392-246615079 |
chr1:246586841 |
rs10924727 |
SMYD3 |
Creatinine levels |
intron |
9.05e-06 |
GWASdb |
| chr1:246566392-246615079 |
chr1:246602240 |
rs10924730 |
SMYD3 |
Multiple complex diseases |
intron |
2.28e-05 |
GWASdb |
| chr1:245897934-245979502 |
chr1:245915582 |
rs2185368 |
SMYD3 |
Response to taxane treatment (placlitaxel) |
intron |
0.000271 |
GWASdb |
| chr1:245897934-245979502 |
chr1:245926038 |
rs12088988 |
SMYD3 |
Multiple complex diseases |
intron |
0.00065 |
GWASdb |
| chr1:245897934-245979502 |
chr1:245926485 |
rs2817506 |
SMYD3 |
Multiple complex diseases |
intron |
0.000447 |
GWASdb |
| chr1:245897934-245979502 |
chr1:245928778 |
rs2791380 |
SMYD3 |
Multiple complex diseases |
intron |
3e-04 |
GWASdb |
| chr1:245897934-245979502 |
chr1:245932792 |
rs2247524 |
SMYD3 |
Response to taxane treatment (placlitaxel) |
intron |
0.000301 |
GWASdb |
| chr1:245897934-245979502 |
chr1:245960086 |
rs2817478 |
SMYD3 |
Insulin resistance |
intron |
8.82e-05 |
GWASdb |
| chr1:245897934-245979502 |
chr1:245960306 |
rs2791393 |
SMYD3 |
Urinary metabolites |
intron |
7.2e-06 |
GWASdb |
| chr1:245897934-245979502 |
chr1:245960306 |
rs2791393 |
SMYD3 |
Insulin resistance |
intron |
4.53e-05 |
GWASdb |
| chr1:245897934-245979502 |
chr1:245962202 |
rs2817475 |
SMYD3 |
Nicotine smoking |
intron |
0.000467 |
GWASdb |
| chr1:245897934-245979502 |
chr1:245917498 |
rs116335148 |
SMYD3, LOC105373269 |
Post bronchodilator FEV1 |
intron_variant |
4e-06 |
GWAS_Catalog |
| chr1:245897934-245979502 |
chr1:245919582 |
rs116647499 |
LOC105373269, SMYD3 |
Post bronchodilator FEV1 |
intron_variant |
4e-06 |
GWAS_Catalog |
| chr1:245897934-245979502 |
chr1:245913962 |
rs115107872 |
SMYD3, LOC105373269 |
Post bronchodilator FEV1 |
intron_variant |
4e-06 |
GWAS_Catalog |
| chr1:245933024-245960563 |
chr1:245960086 |
rs2817478 |
SMYD3 |
Insulin resistance |
intron |
8.82e-05 |
GWASdb |
| chr1:245933024-245960563 |
chr1:245960306 |
rs2791393 |
SMYD3 |
Urinary metabolites |
intron |
7.2e-06 |
GWASdb |
| chr1:245933024-245960563 |
chr1:245960306 |
rs2791393 |
SMYD3 |
Insulin resistance |
intron |
4.53e-05 |
GWASdb |
| chr1:246577198-246614857 |
chr1:246586841 |
rs10924727 |
SMYD3 |
Creatinine levels |
intron |
9.05e-06 |
GWASdb |
| chr1:246577198-246614857 |
chr1:246602240 |
rs10924730 |
SMYD3 |
Multiple complex diseases |
intron |
2.28e-05 |
GWASdb |
| chr1:245905150-245972195 |
chr1:245915582 |
rs2185368 |
SMYD3 |
Response to taxane treatment (placlitaxel) |
intron |
0.000271 |
GWASdb |
| chr1:245905150-245972195 |
chr1:245926038 |
rs12088988 |
SMYD3 |
Multiple complex diseases |
intron |
0.00065 |
GWASdb |
| chr1:245905150-245972195 |
chr1:245926485 |
rs2817506 |
SMYD3 |
Multiple complex diseases |
intron |
0.000447 |
GWASdb |
| chr1:245905150-245972195 |
chr1:245928778 |
rs2791380 |
SMYD3 |
Multiple complex diseases |
intron |
3e-04 |
GWASdb |
| chr1:245905150-245972195 |
chr1:245932792 |
rs2247524 |
SMYD3 |
Response to taxane treatment (placlitaxel) |
intron |
0.000301 |
GWASdb |
| chr1:245905150-245972195 |
chr1:245960086 |
rs2817478 |
SMYD3 |
Insulin resistance |
intron |
8.82e-05 |
GWASdb |
| chr1:245905150-245972195 |
chr1:245960306 |
rs2791393 |
SMYD3 |
Urinary metabolites |
intron |
7.2e-06 |
GWASdb |
| chr1:245905150-245972195 |
chr1:245960306 |
rs2791393 |
SMYD3 |
Insulin resistance |
intron |
4.53e-05 |
GWASdb |
| chr1:245905150-245972195 |
chr1:245962202 |
rs2817475 |
SMYD3 |
Nicotine smoking |
intron |
0.000467 |
GWASdb |
| chr1:245905150-245972195 |
chr1:245917498 |
rs116335148 |
SMYD3, LOC105373269 |
Post bronchodilator FEV1 |
intron_variant |
4e-06 |
GWAS_Catalog |
| chr1:245905150-245972195 |
chr1:245919582 |
rs116647499 |
LOC105373269, SMYD3 |
Post bronchodilator FEV1 |
intron_variant |
4e-06 |
GWAS_Catalog |
| chr1:245905150-245972195 |
chr1:245913962 |
rs115107872 |
SMYD3, LOC105373269 |
Post bronchodilator FEV1 |
intron_variant |
4e-06 |
GWAS_Catalog |
| chr1:245933154-245978118 |
chr1:245960086 |
rs2817478 |
SMYD3 |
Insulin resistance |
intron |
8.82e-05 |
GWASdb |
| chr1:245933154-245978118 |
chr1:245960306 |
rs2791393 |
SMYD3 |
Urinary metabolites |
intron |
7.2e-06 |
GWASdb |
| chr1:245933154-245978118 |
chr1:245960306 |
rs2791393 |
SMYD3 |
Insulin resistance |
intron |
4.53e-05 |
GWASdb |
| chr1:245933154-245978118 |
chr1:245962202 |
rs2817475 |
SMYD3 |
Nicotine smoking |
intron |
0.000467 |
GWASdb |
| chr1:246221446-246281563 |
chr1:246223120 |
rs6693295 |
SMYD3 |
Migraine with aura |
intron |
6e-06 |
GWASdb |
| chr1:246221446-246281563 |
chr1:246223120 |
rs6693295 |
SMYD3 |
Migraine - clinic-based |
intron |
9e-06 |
GWASdb |
| chr1:246221446-246281563 |
chr1:246241574 |
rs61839075 |
SMYD3 |
Sarcoidosis |
intron |
3.939e-05 |
GWASdb |
| chr1:246220855-246295045 |
chr1:246223120 |
rs6693295 |
SMYD3 |
Migraine with aura |
intron |
6e-06 |
GWASdb |
| chr1:246220855-246295045 |
chr1:246223120 |
rs6693295 |
SMYD3 |
Migraine - clinic-based |
intron |
9e-06 |
GWASdb |
| chr1:246220855-246295045 |
chr1:246241574 |
rs61839075 |
SMYD3 |
Sarcoidosis |
intron |
3.939e-05 |
GWASdb |
| chr1:246312879-246390453 |
chr1:246319482 |
rs4654092 |
SMYD3 |
Prostate cancer |
intron |
1.74e-05 |
GWASdb |
| chr1:246312879-246390453 |
chr1:246330176 |
rs4654216 |
SMYD3 |
Multiple complex diseases |
intron |
0.00077 |
GWASdb |
| chr1:246312879-246390453 |
chr1:246364592 |
rs10924545 |
SMYD3 |
Multiple complex diseases |
intron |
0.000915 |
GWASdb |
| chr1:246312879-246390453 |
chr1:246369599 |
rs7539358 |
SMYD3 |
Multiple complex diseases |
intron |
0.000708 |
GWASdb |
| chr1:246312879-246390453 |
chr1:246372880 |
rs10802346 |
SMYD3 |
Fractional exhaled nitric oxide (childhood) |
intron |
7.17e-05 |
GWASdb |
| chr1:246312879-246390453 |
chr1:246372880 |
rs10802346 |
SMYD3 |
Fractional exhaled nitric oxide (childhood) |
intron |
8e-06 |
GWASdb |
| chr1:246312879-246390453 |
chr1:246378041 |
rs10924556 |
SMYD3 |
Multiple complex diseases |
intron |
0.000488 |
GWASdb |
| chr1:246221570-246283217 |
chr1:246223120 |
rs6693295 |
SMYD3 |
Migraine with aura |
intron |
6e-06 |
GWASdb |
| chr1:246221570-246283217 |
chr1:246223120 |
rs6693295 |
SMYD3 |
Migraine - clinic-based |
intron |
9e-06 |
GWASdb |
| chr1:246221570-246283217 |
chr1:246241574 |
rs61839075 |
SMYD3 |
Sarcoidosis |
intron |
3.939e-05 |
GWASdb |
| chr1:246147980-246474515 |
chr1:246148791 |
rs4654180 |
SMYD3 |
Diabetic nephropathy |
intron |
3.68e-05 |
GWASdb |
| chr1:246147980-246474515 |
chr1:246152478 |
rs10802308 |
SMYD3 |
Multiple complex diseases |
intron |
0.000129 |
GWASdb |
| chr1:246147980-246474515 |
chr1:246162256 |
rs2105158 |
SMYD3 |
Diabetic nephropathy |
intron |
2.06e-05 |
GWASdb |
| chr1:246147980-246474515 |
chr1:246203214 |
rs12084862 |
SMYD3 |
Migraine |
intron |
8.2e-06 |
GWASdb |
| chr1:246147980-246474515 |
chr1:246223120 |
rs6693295 |
SMYD3 |
Migraine with aura |
intron |
6e-06 |
GWASdb |
| chr1:246147980-246474515 |
chr1:246223120 |
rs6693295 |
SMYD3 |
Migraine - clinic-based |
intron |
9e-06 |
GWASdb |
| chr1:246147980-246474515 |
chr1:246241574 |
rs61839075 |
SMYD3 |
Sarcoidosis |
intron |
3.939e-05 |
GWASdb |
| chr1:246147980-246474515 |
chr1:246310748 |
rs6692380 |
SMYD3 |
Type 2 diabetes |
intron |
0.000611 |
GWASdb |
| chr1:246147980-246474515 |
chr1:246319482 |
rs4654092 |
SMYD3 |
Prostate cancer |
intron |
1.74e-05 |
GWASdb |
| chr1:246147980-246474515 |
chr1:246330176 |
rs4654216 |
SMYD3 |
Multiple complex diseases |
intron |
0.00077 |
GWASdb |
| chr1:246147980-246474515 |
chr1:246364592 |
rs10924545 |
SMYD3 |
Multiple complex diseases |
intron |
0.000915 |
GWASdb |
| chr1:246147980-246474515 |
chr1:246369599 |
rs7539358 |
SMYD3 |
Multiple complex diseases |
intron |
0.000708 |
GWASdb |
| chr1:246147980-246474515 |
chr1:246372880 |
rs10802346 |
SMYD3 |
Fractional exhaled nitric oxide (childhood) |
intron |
7.17e-05 |
GWASdb |
| chr1:246147980-246474515 |
chr1:246372880 |
rs10802346 |
SMYD3 |
Fractional exhaled nitric oxide (childhood) |
intron |
8e-06 |
GWASdb |
| chr1:246147980-246474515 |
chr1:246378041 |
rs10924556 |
SMYD3 |
Multiple complex diseases |
intron |
0.000488 |
GWASdb |
| chr1:246147980-246474515 |
chr1:246393636 |
rs4636424 |
SMYD3 |
Multiple complex diseases |
intron |
0.000459 |
GWASdb |
| chr1:246147980-246474515 |
chr1:246394175 |
rs10924576 |
SMYD3 |
Multiple complex diseases |
intron |
0.000225 |
GWASdb |
| chr1:246147980-246474515 |
chr1:246394232 |
rs10924577 |
SMYD3 |
Multiple complex diseases |
intron |
0.000385 |
GWASdb |
| chr1:246147980-246474515 |
chr1:246394320 |
rs10924579 |
SMYD3 |
Multiple complex diseases |
intron |
0.000341 |
GWASdb |
| chr1:246147980-246474515 |
chr1:246454368 |
rs2027372 |
SMYD3 |
Glioma (high-grade) |
intron |
2.4e-06 |
GWASdb |
| chr1:246147980-246474515 |
chr1:246209578 |
rs10802346 |
SMYD3 |
Fractional exhaled nitric oxide (childhood) |
intron_variant |
8e-06 |
GWAS_Catalog |
| chr1:246220902-246284756 |
chr1:246223120 |
rs6693295 |
SMYD3 |
Migraine with aura |
intron |
6e-06 |
GWASdb |
| chr1:246220902-246284756 |
chr1:246223120 |
rs6693295 |
SMYD3 |
Migraine - clinic-based |
intron |
9e-06 |
GWASdb |
| chr1:246220902-246284756 |
chr1:246241574 |
rs61839075 |
SMYD3 |
Sarcoidosis |
intron |
3.939e-05 |
GWASdb |
| chr1:246313511-246352731 |
chr1:246319482 |
rs4654092 |
SMYD3 |
Prostate cancer |
intron |
1.74e-05 |
GWASdb |
| chr1:246313511-246352731 |
chr1:246330176 |
rs4654216 |
SMYD3 |
Multiple complex diseases |
intron |
0.00077 |
GWASdb |
| chr1:246230185-246272317 |
chr1:246241574 |
rs61839075 |
SMYD3 |
Sarcoidosis |
intron |
3.939e-05 |
GWASdb |
| chr1:246230257-246280604 |
chr1:246241574 |
rs61839075 |
SMYD3 |
Sarcoidosis |
intron |
3.939e-05 |
GWASdb |
| chr1:245933063-245998572 |
chr1:245960086 |
rs2817478 |
SMYD3 |
Insulin resistance |
intron |
8.82e-05 |
GWASdb |
| chr1:245933063-245998572 |
chr1:245960306 |
rs2791393 |
SMYD3 |
Urinary metabolites |
intron |
7.2e-06 |
GWASdb |
| chr1:245933063-245998572 |
chr1:245960306 |
rs2791393 |
SMYD3 |
Insulin resistance |
intron |
4.53e-05 |
GWASdb |
| chr1:245933063-245998572 |
chr1:245962202 |
rs2817475 |
SMYD3 |
Nicotine smoking |
intron |
0.000467 |
GWASdb |
| chr1:245933063-245998572 |
chr1:245989211 |
rs10924342 |
SMYD3 |
Multiple complex diseases |
intron |
4.04e-05 |
GWASdb |
| chr1:245933063-245998572 |
chr1:245997603 |
rs7537586 |
SMYD3 |
Multiple complex diseases |
intron |
8.96e-05 |
GWASdb |
| chr1:245933063-245998572 |
chr1:245997919 |
rs6689627 |
SMYD3 |
Multiple complex diseases |
intron |
0.000335 |
GWASdb |
| chr1:246019177-246045919 |
chr1:246027410 |
rs10924366 |
SMYD3 |
Multiple complex diseases |
intron |
0.000935 |
GWASdb |
| chr1:245933430-245999660 |
chr1:245960086 |
rs2817478 |
SMYD3 |
Insulin resistance |
intron |
8.82e-05 |
GWASdb |
| chr1:245933430-245999660 |
chr1:245960306 |
rs2791393 |
SMYD3 |
Urinary metabolites |
intron |
7.2e-06 |
GWASdb |
| chr1:245933430-245999660 |
chr1:245960306 |
rs2791393 |
SMYD3 |
Insulin resistance |
intron |
4.53e-05 |
GWASdb |
| chr1:245933430-245999660 |
chr1:245962202 |
rs2817475 |
SMYD3 |
Nicotine smoking |
intron |
0.000467 |
GWASdb |
| chr1:245933430-245999660 |
chr1:245989211 |
rs10924342 |
SMYD3 |
Multiple complex diseases |
intron |
4.04e-05 |
GWASdb |
| chr1:245933430-245999660 |
chr1:245997603 |
rs7537586 |
SMYD3 |
Multiple complex diseases |
intron |
8.96e-05 |
GWASdb |
| chr1:245933430-245999660 |
chr1:245997919 |
rs6689627 |
SMYD3 |
Multiple complex diseases |
intron |
0.000335 |
GWASdb |
| chr1:246300396-246321129 |
chr1:246310748 |
rs6692380 |
SMYD3 |
Type 2 diabetes |
intron |
0.000611 |
GWASdb |
| chr1:246300396-246321129 |
chr1:246319482 |
rs4654092 |
SMYD3 |
Prostate cancer |
intron |
1.74e-05 |
GWASdb |